Brief: Sonoma Pharmaceuticals Reports Qtrly Loss Per Share Of $0.77
July 10 (Reuters) - Sonoma Pharmaceuticals Inc SNOA.O :
* SONOMA PHARMACEUTICALS REPORTS FISCAL YEAR AND FOURTH
QUARTER
2020 FINANCIAL RESULTS
* Q4 REVENUE ROSE 5 PERCENT TO $4.6 MILLION
* QTRLY LOSS PER SHARE $0.77
* AS OF MARCH 31, 2020, SONOMA HAD CASH AND CASH EQUIVALENTS
OF
$3.7 MILLION
Source text for Eikon: ID:nBw7HWrJGa
Further company coverage: SNOA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Sonoma Pharmaceuticals
See all newsSonoma Pharmaceuticals Q1 revenue rises on US growth
Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth
Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
Brief: Sonoma Pharmaceuticals Inc - Offers Units In Public Offering For Gross Proceeds Of $5 Million - SEC Filing